Quantum BioPharma Ltd. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
QNTM Nasdaq 2830 www.fsdpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Quantum BioPharma Ltd.

Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and Parts of Central and South America - Oct 7th, 2024 12:40 pm
Quantum Biopharma Provides Corporate Update - Sep 28th, 2024 12:06 am
Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US - Sep 25th, 2024 1:20 pm
Quantum BioPharma Closes Private Placement Offering - Sep 14th, 2024 12:00 am
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis - Sep 9th, 2024 11:30 am
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements - Sep 6th, 2024 11:30 pm
Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80 - Aug 30th, 2024 2:30 pm
Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can "own NOW and what’s NEXT" - Aug 30th, 2024 11:30 am
Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update - Aug 23rd, 2024 11:30 pm
FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol "QNTM" - Aug 15th, 2024 10:00 am